Pharmaceuticals
SC blasts manner of stalling Sun-Ranbaxy merger
21 May 2014
Sun Pharma denied the charge but said the share purchase by Silver Street, a limited-liability partnership firm owned by two subsidiaries of Sun Pharma, was being annulled
AstraZeneca rejects Pfizer’s third takeover offer
19 May 2014
AstraZeneca said that Pfizer’s tax-driven inversion structure, which is a key part of its proposal, has already been the subject of intense public and governmental scrutiny
FDA forces Wockhardt to withdraw yet another generic drug from US
17 May 2014
Amid mounting troubles for India’s generic drugs industry, Wockhardt Ltd is recalling over 100,000 bottles of a high blood pressure drug from the US market after they failed to meet FDA standards
Abbott to acquire Chile's CFR Pharmaceuticals in a $2.9 bn deal
17 May 2014
This is Abbott’s first multi-billion dollar deal after it spun off some of its research-based pharmaceuticals business last year
GSK’s former China head charged with bribery
14 May 2014
GSK said that some of its senior Chinese executives appeared to have broken the law
AstraZeneca snubs Pfizer’s “opportunistic” bid
13 May 2014
Botox maker Allergan rejects Valeant's $45.7-b hostile bid
12 May 2014
Allergan Inc today rejected the hostile takeover offer from Canada’s Valeant Pharmaceuticals International Inc, saying that the $45.7-billion bid substantially undervalued the company
Cipla buys 14.6% stake in Chase Pharma to support Alzheimer treatment
12 May 2014
The disease costs the US alone $203 billion annually with projections to reach $1.2 trillion by 2050
Pfizer seeks to allay fears over AstraZeneca deal
07 May 2014
Pfizer says the merger with AstraZeneca would bolster innovative science and speed up the development of new treatments
Merck & Co to sell consumer care business to Germany's Bayer for $14.2 bn
06 May 2014
The deal, which will make Bayer the second-biggest over-the-counter drugs (OTC) maker after Johnson & Johnson, is the largest in the German healthcare industry after Bayer outbid Merck to acquire Schering in 2006 for $21.5 billion
Sterigenics raises bid for Canadian isotope supplier Nordion to $758 mn
06 May 2014
Nordion is one of the world's leading producers of molybdenum-99, an isotope used in medical imaging and a leading provider of sterilisation technologies and medical isotopes used for the prevention, diagnosis and treatment of diseases
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
